Yet there are other questions.    says he’s also a 10%   investor in a mysterious biotech startup called NeurMedix that   plans its own Regulation A+  complete with   O’Hurley on the offering page. " "     also owns an   company called  which is planning a     soon. The details of that company are vague, but   O’Hurley makes an appearance there too. 